LIR-1 is an inhibitory receptor also known as immunoglobulin-like transcript 2 (ILT-2)/CD85j or leukocyte immunoglobulin-like receptor, subfamily B member 1 (LILRB1). LIR receptors are type I transmembrane proteins of the immunoglobulin-like receptor superfamily (Cosman, Immunity, 7 (1997), pp. 273–282). They recognize classical HLA class I molecules, while LIR-1 can also interact with nonclassical HLA class I and bacteria with low binding affinities (Cytokine and Growth Factor Reviews, vol. 11, no. 3, pp. 209–217, 2000). LIRs are expressed on subsets of NK cells and T cells, as well as on monocytes, B cells, and DC, with the widest distribution for LIR-1 (Nakayama, Journal of Immunology, vol. 178, no. 7, pp. 4250–4259, 2007). Our anti-LIR-1 antibody LIR1.14 works in ELISA (on immunogen), IF and FACS (on human cells).
Catalog No.: HR-Lympho-01
Host Species: Mouse
Antigen/Immunogen: The immunogen consisted of LIR-1 ectodomain fused to the hIgG1 Fc fragment and was produced from the supernatant of HEK 293T cells
Tested Applications: ELISA; FACS; IF; IHC
The immunogen consisted of LIR-1 ectodomain fused to the hIgG1 Fc fragment and was produced from the supernatant of HEK 293T cells
ELISA; FACS; IF; IHC
€120.00 – €500.00
|STORAGE||Long term -20 °C, short term +4 °C. Avoid freeze-thaw cycles.|
|LIGHT CHAIN TYPE||kappa|
Mouse NKp46, also known as NCR-1, CD335 or MAR-1, is an activating receptor, member of the natural cytotoxicity receptor (NCR) family that triggers lytic activities of NK cells.
PSG1 is the most abundantly expressed of the 11 different pregnancy-specific glycoproteins (PSGs) which are members immunoglobulin superfamily (Blois, Mucosal Immunol, 2014; 7:348–358).
Human activating receptor natural-killer group 2, member D (NKG2D) is a 35 kDa type II transmembrane glycoprotein and a part of CD94/NKG2 family of C-type lectin-like receptors
V-set and transmembrane domain containing 1 (VSTM1) encodes two main splicing isoforms, VSTM1-v1 and VSTM1-v2 (Guo, Cell Immunol 2012, 278: 136–142; Steevels, J Immunol. 2010;184:4741–8).
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by <1-8% NK cells and subsets of CD8+ T cells (Melero et al., 1994, The Journal of Immunology, 152(4)).